Literature DB >> 26819460

Emerging Roles of PCSK9: More Than a One-Trick Pony.

Kathryn J Moore1, Ira J Goldberg2.   

Abstract

Entities:  

Keywords:  amyloid precursor protein secretases; antigens, cd36; fatty acids, nonesterified; proprotein convertases; receptors, LDL

Mesh：

Substances：

Year:  2016        PMID： 26819460      PMCID： PMC4732575          DOI： 10.1161/ATVBAHA.115.306756

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  13 in total

1.  A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.

Authors:  Ingrid K Kotowski; Alexander Pertsemlidis; Amy Luke; Richard S Cooper; Gloria L Vega; Jonathan C Cohen; Helen H Hobbs
Journal:  Am J Hum Genet       Date:  2006-01-20       Impact factor: 11.025

2.  Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice.

Authors:  C T Coburn; F F Knapp; M Febbraio; A L Beets; R L Silverstein; N A Abumrad
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

3.  Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.

Authors:  Kara N Maxwell; Edward A Fisher; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-27       Impact factor: 11.205

4.  Regulation of epithelial sodium channel trafficking by proprotein convertase subtilisin/kexin type 9 (PCSK9).

Authors:  Vikas Sharotri; Daniel M Collier; Diane R Olson; Ruifeng Zhou; Peter M Snyder
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

5.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

Authors:  Marianne Abifadel; Mathilde Varret; Jean-Pierre Rabès; Delphine Allard; Khadija Ouguerram; Martine Devillers; Corinne Cruaud; Suzanne Benjannet; Louise Wickham; Danièle Erlich; Aurélie Derré; Ludovic Villéger; Michel Farnier; Isabel Beucler; Eric Bruckert; Jean Chambaz; Bernard Chanu; Jean-Michel Lecerf; Gerald Luc; Philippe Moulin; Jean Weissenbach; Annick Prat; Michel Krempf; Claudine Junien; Nabil G Seidah; Catherine Boileau
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

6.  Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.

Authors:  Da-Wei Zhang; Thomas A Lagace; Rita Garuti; Zhenze Zhao; Meghan McDonald; Jay D Horton; Jonathan C Cohen; Helen H Hobbs
Journal:  J Biol Chem       Date:  2007-04-23       Impact factor: 5.157

7.  The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.

Authors:  Steve Poirier; Gaetan Mayer; Suzanne Benjannet; Eric Bergeron; Jadwiga Marcinkiewicz; Nasha Nassoury; Harald Mayer; Johannes Nimpf; Annik Prat; Nabil G Seidah
Journal:  J Biol Chem       Date:  2007-11-26       Impact factor: 5.157

8.  PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression.

Authors:  Patrick Labonté; Syntia Begley; Carl Guévin; Marie-Claude Asselin; Nasha Nassoury; Gaétan Mayer; Annik Prat; Nabil G Seidah
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

Review 9.  CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.

Authors:  Roy L Silverstein; Maria Febbraio
Journal:  Sci Signal       Date:  2009-05-26       Impact factor: 8.192

10.  PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver.

Authors:  Annie Demers; Samaneh Samami; Benjamin Lauzier; Christine Des Rosiers; Emilienne Tudor Ngo Sock; Huy Ong; Gaetan Mayer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-22       Impact factor: 8.311
View more
  4 in total

Review 1.  Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

Authors:  C Shad Thaxton; Jonathan S Rink; Pratap C Naha; David P Cormode
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

Review 2.  Protein-Based Nanoparticles as Drug Delivery Systems.

Authors:  Seyoung Hong; Dong Wook Choi; Hong Nam Kim; Chun Gwon Park; Wonhwa Lee; Hee Ho Park
Journal:  Pharmaceutics       Date:  2020-06-29       Impact factor: 6.321

Review 3.  Translational and Therapeutic Approaches to the Understanding and Treatment of Dyslipidemia.

Authors:  Hanrui Zhang; Thomas Q de Aguiar Vallim; Catherine Martel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07       Impact factor: 10.514

4.  Thrombocytopenia Complicating Transcatheter Aortic Valve Implantation: Differences Between Two New-Generation Devices.

Authors:  Nicola Corcione; Simona Romano; Alberto Morello; Paolo Ferraro; Michele Cimmino; Michele Albanese; Martina Tufano; Daniela Capasso; Salvatore Buonpane; Salvatore Giordano; Martino Pepe; Giuseppe Biondi-Zoccai; Maria Fiammetta Romano; Arturo Giordano
Journal:  J Cardiovasc Transl Res       Date:  2021-03-15       Impact factor: 4.132
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.